Security · featured owners

MLTX Moonlake Immunotherapeutics

CLASS A ORD Equity as of 2026 Q2 among managers we track

1 exit

holders

sorted by value · long equity only · current book 2026 Q2 · exits show last held size · open a manager for their book

					history
David Witzke - Avidity Partners Management exited 2026 Q2 last 2026 Q1	0.19%	Exit −0.19 pp	50,000	$932K	history

0 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric	FY2023	FY2024	FY2025
Net income	-$36.01M	-$118.94M	-$227.32M

Balance sheet

Metric	FY2023	FY2024	FY2025
Total current assets	$514.17M	$474.29M	$421.69M
Total non-current assets	$12.37M	$3.64M	$2.74M
Total assets	$526.54M	$477.93M	$424.43M
Total current liabilities	$9.97M	$22.46M	$45.48M
Total non-current liabilities	$3.08M	$2.08M	$74.47M
Total equity	$495.68M	$446.83M	$304.48M

Cash flow

Metric	FY2023	FY2024	FY2025
Cash from operations	-$42.78M	-$116.59M	-$196.01M
Cash from investing	-$25.18M	-$205.6M	$202.99M
Cash from financing	$479.7M	$51.31M	$146M
Net change in cash	$411.66M	-$270.74M	$154.09M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders